“cardiovascular” Archives

Entry Author Date Location
70% Repatha Cut? Amgen Counters With Own Study To Justify Price 08/23/17 National
In Cholesterol Drug Price Fight, Real Message Is “Wait Til Next Year” 08/18/16 National
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit Ann Arbor
Duke Long-Term Health Study Aims To Join Obama’s Precision Med Plan 06/24/15 Raleigh Durham
Cardio Study Gives Life To Armetheon’s Blood-Thinning Drug 02/09/15 San Francisco
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time 10/03/13 National
Merck on Track to Seek Approval for Two Heart Drugs in ’13 08/27/12 New York
CardioKinetix Clears 2-Year Study with Implant for Heart Failure 05/18/12 San Francisco
NextWave Pharma Snaps Up $45M 01/11/11 San Francisco
BG Medicine Wins FDA OK, Primes Pump for Second Shot at IPO 11/24/10 Boston
$17M for Stent Maker TriReme 10/12/10 San Francisco
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010 09/20/10 San Francisco
Swedish Names Chief Scientist 09/08/10 Seattle
Aastrom Shows Off Vascular Results 06/11/10 Detroit Ann Arbor
Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial 12/23/09 San Diego
NormOxys Emerges from Stealth with New Class of Oxygen Drugs for Cancer, Heart Failure 12/04/09 Boston
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis 01/21/09 San Diego
Page 1 of 1